A

EORTC-1607-GITCG/ABC-09: Open-label first-line, single-arm phase II study of CisGem combined with pembrolizumab in patients with advanced or metastatic biliary tract cancer

Translational Oncology

Authors 0

  1. Author list not loaded yet.

Cited by 0 stored of 0

References 1

1 result